Oxyntomodulin and glucagon-like peptide-1 differentially regulate murine food intake and energy expenditure.
@article{Baggio2004OxyntomodulinAG, title={Oxyntomodulin and glucagon-like peptide-1 differentially regulate murine food intake and energy expenditure.}, author={Laurie L. Baggio and Qingling Huang and Theodore J. Brown and Daniel J. Drucker}, journal={Gastroenterology}, year={2004}, volume={127 2}, pages={ 546-58 } }
BACKGROUND & AIMS
Gut-derived peptides including ghrelin, cholecystokinin (CCK), peptide YY (PYY), glucagon-like peptide (GLP-1), and GLP-2 exert overlapping actions on energy homeostasis through defined G-protein-coupled receptors (GPCRs). The proglucagon-derived peptide (PGDP) oxyntomodulin (OXM) is cosecreted with GLP-1 and inhibits feeding in rodents and humans; however, a distinct receptor for OXM has not been identified.
METHODS
We examined the mechanisms mediating oxyntomodulin action…
341 Citations
The glucagon-like peptide-1 receptor agonist oxyntomodulin enhances beta-cell function but does not inhibit gastric emptying in mice.
- Biology, MedicineEndocrinology
- 2008
The proglucagon gene gives rise to multiple peptides that play diverse roles in the control of energy intake, gut motility, and nutrient disposal. Glucagon-like peptide-1 (GLP-1), a 30-amino-acid…
Oxyntomodulin Differentially Affects Glucagon-Like Peptide-1 Receptor β-Arrestin Recruitment and Signaling through Gα
- BiologyJournal of Pharmacology and Experimental Therapeutics
- 2007
Bioluminescence resonance energy transfer2 assays are applied to measure agonist-induced recruitment of βarrestins and G-protein-coupled receptor kinase (GRK) 2 to the GLP-1 receptor in addition to traditional measurements of second messenger generation to suggest that oxyntomodulin and glucagon are biased ligands on the GLp-1 receptors.
Effects of glucagon-like peptide 1 and oxyntomodulin on neuronal activity of ghrelin-sensitive neurons in the hypothalamic arcuate nucleus.
- BiologyAmerican journal of physiology. Regulatory, integrative and comparative physiology
- 2010
It is demonstrated that GLP-1 and OXM directly and similarly alter neuronal activity in the ARC, probably via a common GLp-1R-mediated mechanism, suggesting the existence of a common mode of action for these hormones.
Differential effects of oxyntomodulin and GLP-1 on glucose metabolism.
- Biology, MedicineAmerican journal of physiology. Endocrinology and metabolism
- 2012
Activation of the GCGR seems to partially attenuate the acute beneficial effects on glucose and contributes to the insulinotropic action of oxyntomodulin.
Glucagon-like peptide-1 inhibits insulinotropic effects of oxyntomodulin and glucagon in cattle.
- Chemistry, MedicineDomestic animal endocrinology
- 2012
Oxyntomodulin increases intrinsic heart rate in mice independent of the glucagon-like peptide-1 receptor.
- BiologyAmerican journal of physiology. Regulatory, integrative and comparative physiology
- 2007
Multiple modes of action of OXM are suggested: 1) it directly elevates murine intrinsic HR through a GLP-1R-independent mechanism, perhaps via the glucagon receptor or an unidentified OXM receptor, and 2) it lowers food intake, activity, and Tb in aGLP- 1R-dependent fashion.
Differences in the Central Anorectic Effects of Glucagon-Like Peptide-1 and Exendin-4 in Rats
- Biology, MedicineDiabetes
- 2009
Data suggest that although GLP-1rs are required for the actions of Ex4, there appear to be key differences in how Glucagon-like peptide and Ex4 interact with central nervous system GLp-1r and in how Ex4 interacts withGLP- 1r in the brain versus the periphery.
The glucagon-like peptide 1 receptor is essential for postprandial lipoprotein synthesis and secretion in hamsters and mice
- Medicine, BiologyDiabetologia
- 2009
Potentiation of endogenous incretin action via DPP-4 inhibition or pharmacological augmentation of GLP-1R signalling reduces intestinal secretion of triacylglycerol, cholesterol and ApoB-48 and abolished the hypolipidaemic effect of sitagliptin.
Glucagon-Like Peptide 1/Glucagon Receptor Dual Agonism Reverses Obesity in Mice
- Biology, MedicineDiabetes
- 2009
Sustained GLP1R/GCGR dual agonism reverses obesity in DIO mice and is a novel therapeutic approach to the treatment of obesity.
A novel long-acting oxyntomodulin analogue eliminates diabetes and obesity in mice.
- Biology, MedicineEuropean journal of medicinal chemistry
- 2020
References
SHOWING 1-10 OF 82 REFERENCES
Glucagon-like peptide 1 as a regulator of food intake and body weight: therapeutic perspectives.
- Medicine, BiologyEuropean journal of pharmacology
- 2002
A role for glucagon-like peptide-1 in the central regulation of feeding
- BiologyNature
- 1996
It is reported here that intracerebroventricular (ICV) GLP-1 powerfully inhibits feeding in fasted rats, and this findings suggest that central GLp-1 is a new physiological mediator of satiety.
Oxyntomodulin: a cAMP-dependent stimulus of rat parietal cell function via the receptor for glucagon-like peptide-1 (7-36)NH2.
- BiologyDigestion
- 1996
It is concluded that, by interacting with parietal cell receptors for GLP-1 (7-36)NH2, oxyntomodulin, but notGLP-2, directly stimulates H+ production by activating the adenylate cyclase.
Minireview: the glucagon-like peptides.
- Biology, MedicineEndocrinology
- 2001
The actions of these peptides on nutrient absorption and energy homeostasis and the efficacy of GLP-1 andGLP-2 in animal models of diabetes and intestinal diseases, respectively, suggest that analogs ofThese peptides may be clinically useful for the treatment of human disease.
Biological actions and therapeutic potential of the glucagon-like peptides.
- Medicine, BiologyGastroenterology
- 2002
Inhibitors of DP IV activity, or DP IV-resistant glucagon-like peptide analogues, may be alternative therapeutic approaches for treatment of human diseases.
Peripheral oxyntomodulin reduces food intake and body weight gain in rats.
- Biology, MedicineEndocrinology
- 2004
It is reported that peripheral (ip) administration of OXM dose-dependently inhibited both fast-induced and dark-phase food intake without delaying gastric emptying and there was a significant increase in c-fos immunoreactivity in the arcuate nucleus (ARC).
Glucagon-like peptide-1(7–36)amide, oxyntomodulin and glucagon interact with a common receptor in a somatostatin-secreting cell line
- Biology, MedicineRegulatory Peptides
- 1992
The proglucagon-derived peptide, glucagon-like peptide-2, is a neurotransmitter involved in the regulation of food intake
- BiologyNature Medicine
- 2000
Pharmacological and behavioral studies confirmed that glucagon-like-peptide-2 signaling is a specific transmitter inhibiting rodent feeding behavior and with potential long-term effects on body weight homeostasis.
Systemic administration of the long-acting GLP-1 derivative NN2211 induces lasting and reversible weight loss in both normal and obese rats.
- Biology, MedicineDiabetes
- 2001
The present series of experiments show that GLP-1 is fully capable of inhibiting food intake in rats via a peripherally accessible site and may prove efficient as weight-reducing therapeutic agents for overweight patients with type 2 diabetes.
The hepatic vagal reception of intraportal GLP-1 is via receptor different from the pancreatic GLP-1 receptor.
- Biology, MedicineJournal of the autonomic nervous system
- 2000